← SynDRA
TIPEPIDINE
SynDRA canonical compound SYN0028078 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | KCNJ3 |
|---|
| Mechanism of action | g protein signaling inhibitor |
|---|
| Indication | attention-deficit/hyperactivity disorder (adhd) |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
Mechanisms of action (all sources)
- g protein signaling inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
ATC classes
- R05D · COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS
Cross-references
Synonyms
- tipepidine hibenzate
- asverin
- tipedine
- Tipepidina
- AT-327
- CR-662
- CR/662
- CRJ662
- Tipepidinum
- DTXCID402626
- 3-[bis(thiophen-2-yl)methylidene]-1-methylpiperidine
- 3-(bis(thiophen-2-yl)methylidene)-1-methylpiperidine
- RefChem:190102
- R05DB24
- 3-(Di-2-thienylmethylene)-1-methylpiperidine
- Tipedine
- 3-(dithiophen-2-ylmethylidene)-1-methylpiperidine
- Bitiodin
- Tipepidine (INN)
- NCGC00167424-01
- TIPEPIDINE [INN]
- Tipepidine [INN:DCF]
- Tipepidinum [INN-Latin]
- Tipepidina [INN-Spanish]
- BRN 0212554
- Tipepidin
- UNII-2260ZP67IT
- 1-Methyl-3-piperidylidenedi(2-thienyl)methane
- 3-(Di-2-thienylmethylene)-1-methyl-piperidine
- Piperidine, 3-(di-2-thienylmethylene)-1-methyl-
- TIPEPIDINE [MI]
- Piperidine, 3-(di-2-thienylmethyle)-1-methyl-
- TIPEPIDINE [WHO-DD]
- Oprea1_194078
- Oprea1_494302
- CBDivE_006087
- 4-27-00-06328 (Beilstein Handbook Reference)
- SCHEMBL410090
Look up TIPEPIDINE in the interactive SynDRA portal →